• 1
    Institute of Medicine. Safety of silicone implants. National Academy of Sciences, 1999.
  • 2
    Brown JB, Fryer MP, Kollias P, Ohlwiler DA, Templeton JB. Silicone and Teflon prostheses, including full jaw substitution: laboratory and clinical studies of Etheron. Ann Surg 1963; 157: 93243.
  • 3
    Lilla JA, Vistnes LM. Long-term study of reactions to various silicone breast implants in rabbits. Plast Reconstr Surg 1976; 57: 63749.
  • 4
    Schwartz AW, Erich JB. Experimental study of polyvinylformal (ivalon) sponge as a substitute for tissue. Plast Reconstr Surg 1960; 25: 114.
  • 5
    Yoshida SH, Swan S, Teuber SS, Gershwin ME. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci 1995; 56: 1299310.
  • 6
    Potter M, Morrison S, Wiener F, Zhang XK, Miller FW. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J Natl Cancer Inst 1994; 86: 105865.
  • 7
    Berkel H, Birdsell DC, Jenkins H. Breast augmentation: a risk factor for breast cancer? N Engl J Med 1992; 326: 164953.
  • 8
    Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Breast cancer following augmentation mammoplasty (United States). Cancer Causes Control 2000; 11: 81927.
  • 9
    Bryant H, Brasher P. Breast implants and breast cancer—reanalysis of a linkage study. N Engl J Med 1995; 332: 15359.
  • 10
    Deapen DM, Bernstein L, Brody GS. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles Study. Plast Reconstr Surg 1997; 99: 134653.
  • 11
    Friis S, McLaughlin JK, Mellemkjaer L, Kjoller KH, Blot WJ, Boice JDJr, Fraumeni JFJr, Olsen JH. Breast implants and cancer risk in Denmark. Int J Cancer 1997; 71: 9568.
  • 12
    Pukkala E, Boice JDJr, Hovi SL, Hemminki E, Asko-Seljavaara S, Keskimaki I, McLaughlin JK, Pakkanen M, Teppo L. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970–1999. J Long Term Eff Med Implants 2002; 12: 2719.
  • 13
    Brinton LA, Malone KE, Coates RJ, Schoenberg JB, Swanson CA, Daling JR, Stanford JL. Breast enlargement and reduction: results from a breast cancer case-control study. Plast Reconstr Surg 1996; 97: 26975.
  • 14
    Malone KE, Stanford JL, Daling JR, Voigt LF. Implants and breast cancer. Lancet 1992; 339: 1365.
  • 15
    Glasser JW, Lee NC, Wingo PA. Does breast augmentation increase the risk of breast cancer. In: Proceedings of the 1989 EIS conference. Atlanta: Center for Disease Control, Public Health Service, U.S. Department of Health and Human Services, 1989.
  • 16
    IARC. Monographs on the evaluation of carcinogenic risks to humans. Surgical implants and other foreign bodies. Lyon: IARC, 1999.
  • 17
    Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol 2001; 11: 24856.
  • 18
    Brinton LA, Lubin JH, Burich MC, Colton T, Hoover RN. Mortality among augmentation mammoplasty patients. Epidemiology 2001; 12: 3216.
  • 19
    Silverman S, Vescio R, Silver D, Renner S, Weiner S, Berenson J. Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance. Curr Top Microbiol Immunol 1996; 210: 36774.
  • 20
    Rabkin CS, Silverman S, Tricot G, Garland LL, Ballester O, Potter M. The National Cancer Institute Silicone Implant/Multiple Myeloma Registry. Curr Top Microbiol Immunol 1996; 210: 3857.
  • 21
    Goodman CM, Cohen V, Thornby J, Netscher D. The life span of silicone gel breast implants and a comparison of mammography, ultrasonography, and magnetic resonance imaging in detecting implant rupture: a meta-analysis. Ann Plast Surg 1998; 41: 57785; discussion 585–6.
  • 22
    Brown SL, Middleton MS, Berg WA, Soo MS, Pennello G. Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. AJR Am J Roentgenol 2000; 175: 105764.
  • 23
    Governement du Québec, MED-ECHO. 1974–1989.
  • 24
    Howe GR, Lindsay J. A generalized iterative record linkage computer system for use in medical follow-up studies. Comput Biomed Res 1981; 14: 32740.
  • 25
    Aronson KJ, Howe GR. Utility of a surveillance system to detect associations between work and cancer among women in Canada, 1965–1991. J Occup Med 1994; 36: 11749.
  • 26
    Goldberg MS, Carpenter M, Theriault G, Fair M. The accuracy of ascertaining vital status in a historical cohort study of synthetic textiles workers using computerized record linkage to the Canadian Mortality Data Base. Can J Public Health 1993; 84: 2014.
  • 27
    Howe GR. Use of computerized record linkage in follow-up studies of cancer epidemiology in Canada. Natl Cancer Inst Monogr 1985; 67: 11721.
  • 28
    Band PR, Gaudette LA, Hill GB, Holowaty EJ, Huchcroft SA, Johnston GM, Makomaski-Illing EM, Mao Y, Semenciw RM. The making of the canadian cancer registry: cancer incidence in Canada and its regions, 1969–1988. Ottawa: Minster of Supply and Services Canada, 1993.
  • 29
    Schnatter AR, Acquavella JF, Thompson FS, Donaleski D, Theriault G. An analysis of death ascertainment and follow-up through statistics Canada's Mortality Data Base system. Can J Public Health 1990; 81: 605.
  • 30
    Preston DL, Lubin JH, Pierce DA, McConney M. EPICURE: risk regression and data analysis software. Seattle: Hirosoft International Corporation, 1996.
  • 31
    Breslow NE, Day NE.Statistical methods in cancer research: volume IIThe design and analysis of cohort studies. Lyon: IARC, 1987.
  • 32
    Cook LS, Daling JR, Voigt LF, deHart MP, Malone KE, Stanford JL, Weiss NS, Brinton LA, Gammon MD, Brogan D. Characteristics of women with and without breast augmentation. JAMA 1997; 277: 16127.
  • 33
    SAS Institute Inc. SAS, ed 8.0. Cary, NC: SAS Institute, 2003.
  • 34
    Deapen DM, Brody GS. Augmentation mammaplasty and breast cancer: a 5-year update of the Los Angeles study. Plast Reconstr Surg 1992; 89: 6605.
  • 35
    Fryzek JP, Weiderpass E, Signorello LB, Hakelius L, Lipworth L, Blot WJ, McLaughlin JK, Nyren O. Characteristics of women with cosmetic breast augmentation surgery compared with breast reduction surgery patients and women in the general population of Sweden. Ann Plast Surg 2000; 45: 34956.
  • 36
    Kjoller K, Holmich LR, Fryzek JP, Jacobsen PH, Friis S, McLaughlin JK, Lipworth L, Henriksen TF, Jorgensen S, Bittmann S, Olsen JH. Characteristics of women with cosmetic breast implants compared with women with other types of cosmetic surgery and population-based controls in Denmark. Ann Plast Surg 2003; 50: 612.
  • 37
    Brinton LA, Brown SL, Colton T, Burich MC, Lubin J. Characteristics of a population of women with breast implants compared with women seeking other types of plastic surgery. Plast Reconstr Surg 2000; 105: 91927; discussion 928–9.
  • 38
    Deapen DM, Pike MC, Casagrande JT, Brody GS. The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg 1986; 77: 3618.
  • 39
    Miglioretti DL, Rutter CM, Geller BM, Cutter G, Barlow WE, Rosenberg R, Weaver DL, Taplin SH, Ballard-Barbash R, Carney PA, Yankaskas BC, Kerlikowske K. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA 2004; 291: 44250.
  • 40
    Weiss HA, Devesa SS, Brinton LA. Laterality of breast cancer in the United States. Cancer Causes Control 1996; 7: 53943.
  • 41
    Senie RT, Saftlas AF, Brinton LA, Hoover RN. Is breast size a predictor of breast cancer risk or the laterality of the tumor? Cancer Causes Control 1993; 4: 2038.
  • 42
    Kelloff GJ, Lubet RA, Lieberman R, Eisenhauer K, Steele VE, Crowell JA, Hawk ET, Boone CW, Sigman CC. Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev 1998; 7: 6578.
  • 43
    Brinton LA, Persson I, Boice JD,Jr, McLaughlin JK, Fraumeni JFJr. Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer 2001; 91: 47883.
  • 44
    Cook RR, Perkins LL. The prevalence of breast implants among women in the United States. Curr Top Microbiol Immunol 1996; 210: 41925.
  • 45
    Mackillop WJ, Zhang-Salomons J, Boyd CJ, Groome PA. Associations between community income and cancer incidence in Canada and the United States. Cancer 2000; 89: 90112.
  • 46
    Collis N, Coleman D, Foo IT, Sharpe DT. Ten-year review of a prospective randomized controlled trial of textured versus smooth subglandular silicone gel breast implants. Plast Reconstr Surg 2000; 106: 78691.
  • 47
    Collis N, Sharpe DT. Recurrence of subglandular breast implant capsular contracture: anterior versus total capsulectomy. Plast Reconstr Surg 2000; 106: 7927.
  • 48
    Vazquez B, Given KS, Houston GC. Breast augmentation: a review of subglandular and submuscular implantation. Aesthetic Plast Surg 1987; 11: 1015.
  • 49
    Fajardo LL, Harvey JA, McAleese KA, Roberts CC, Granstrom P. Breast cancer diagnosis in women with subglandular silicone gel-filled augmentation implants. Radiology 1995; 194: 85962.
  • 50
    Silverstein MJ, Handel N, Gamagami P. The effect of silicone-gel-filled implants on mammography. Cancer 1991; 68( Suppl 5): 115963.
  • 51
    IARC. IARC monographs on the evaluation of cancer risks of chemicals to humans—some chemcials used in plastics and elastomers. Lyon: IARC, 1986.
  • 52
    Cohney BC, Cohney TB, Hearne VA. Augmentation mammaplasty—a further review of 20 years using the polyurethane-covered prosthesis. J Long Term Eff Med Implants 1992; 1: 26979.
  • 53
    Hester TRJr, Ford NF, Gale PJ, Hammett JL, Raymond R, Turnbull D, Frankos VH, Cohen MB. Measurement of 2,4-toluenediamine in urine and serum samples from women with Meme or Replicon breast implants. Plast Reconstr Surg 1997; 100: 12918.